Nasal NO concentrations and colonization of lower airways with P. aeruginosa are associated with variants in the neuronal NO synthase (NOS1) gene in CF patients Source: Eur Respir J 2001; 18: Suppl. 33, 8s Year: 2001
Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020
Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2007; 30: 286-292 Year: 2007
Detection of Pseudomonas aeruginosa in exhaled breath of cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018
Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004
Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis Source: ERJ Open Res 2015; 1: 00044-2015 Year: 2015
Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis Source: Virtual Congress 2021 – Back to infection basics Year: 2021
Polymorphisms of the IL-10 gene and pseudomonas aeruginosa infection in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006
Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients Source: Eur Respir J 2001; 17: 1267-1270 Year: 2001
Nitric oxide synthase gene expression and its relation with the lung vascular injury in pneumonia of immunosupressed rats Source: Eur Respir J 2005; 26: Suppl. 49, 731s Year: 2005
Relationship betweeen exhaled nitric oxide and clinical pattern in Community-acquired pneumonia patients Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017
Expression of inducible nitiric oxide synthase (iNOS) in airway epithelial cells is reduced in young children with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003
Association between nitric oxide and clinical phenotype in children with CF Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015
Single nucleotide polymorphisms in genes of the innate immunity in cystic fibrosis patients: correlation with lung function and pseudomonas aeruginosa (P.a.) colonisation Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
Protective role of nitric oxide synthases in pulmonary emphysema in mice Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019
Reduced exhaled nitric oxide in infants with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004
Gender specific association of the endothelial nitric oxide synthase (NOS3) gene polymorphisms with allergic diseases Source: Eur Respir J 2005; 26: Suppl. 49, 140s Year: 2005
Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018
Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa Source: Eur Respir J 2003; 22: 503-506 Year: 2003